Derm Cross Linked Hyaluronic Acid For Face
Ingredient: 22mg/ml hyaluronic acid
Specification: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml
Package: Syringe
Recommended use: 1-3 pcs, 12 months apart
Application Area:
Cheek apple muscle, neck lines, forehead lines, eyes, lips, back of hand, nasolabial groove, mouth pouch, puppet lines etc
Product Introduction:
Crosslinking achieves therapeutic specificity: High-density D24+ (24mg/ml) for malar augmentation vs low-modulus D12 (12mg/ml) for perioral rejuvenation. HD20's proprietary RedOptics pigment system correlates with 0.91 color difference from natural lip mucosa, while its vitamin B3/B5 complex shows 29% faster epithelial recovery vs placebo in split-face trials.
Product Display:
Product Details:
Type | Derm |
Ingredient | Cross Linked Hyaluronic Acid Dermal Filler |
Specification | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml |
Cross Link | BDDE chemical cross link |
Texture | Gel |
Elasticity | 250 Pa-400 Pa |
Viscosity | 40Pa-100Pa |
Mean particle size | 200μm-400μm |
Effective content | 20mg/mL |
Cross linker residue | No,or≤0.5ug/g |
Protein residue | ≤20μg/g |
Endotoxin content | <0.5EU/mL |
Swelling degree | 30-50 |
Extruding force | 18N-25N |
Application area | Cheek apple muscle, neck lines, forehead lines, eyes, lips, back of hand, nasolabial groove, mouth pouch, puppet lines etc |
Package | Syringe |
Stoarge | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-3 pcs (vary with each individual |
Recommended interval | 12 month |
Product Package:
Customer Feedbak:
Raw Material Advantages:
1. CLHA demonstrates reduced hygroscopic shrinkage compared to linear HA in low-humidity environments.
2. Cross-linked formulations maintain structural integrity when combined with collagenase inhibitors in cellulite treatments.
Development Process:
Company Introduction:
Dedicated to advancing healthcare, Jinan Grandwill operates at the forefront of medical device development. Our ISO-certified 5,000-sqm manufacturing hub includes 6 production lines and microbial testing labs. With 11 patents and 6 pending innovations, we specialize in sterile, implantable materials free from heavy metals—backed by Class II/III certifications and global regulatory adherence.